Log in to save to my catalogue

Adipose mesenchymal stromal cell function is not affected by methotrexate and azathioprine

Adipose mesenchymal stromal cell function is not affected by methotrexate and azathioprine

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3869447

Adipose mesenchymal stromal cell function is not affected by methotrexate and azathioprine

About this item

Full title

Adipose mesenchymal stromal cell function is not affected by methotrexate and azathioprine

Publisher

United States: Mary Ann Liebert, Inc

Journal title

BioResearch open access, 2013-12, Vol.2 (6), p.431-439

Language

English

Formats

Publication information

Publisher

United States: Mary Ann Liebert, Inc

Subjects

Subjects and topics

More information

Scope and Contents

Contents

Given their capacity to modulate the immune response, adipose mesenchymal stem or stromal cells (ASCs) have been used as therapeutic tools to treat chronic inflammatory and autoimmune diseases both in preclinical and clinical studies. Patients enrolled in such clinical trials are often concomitantly treated with immunomodulatory drugs such as metho...

Alternative Titles

Full title

Adipose mesenchymal stromal cell function is not affected by methotrexate and azathioprine

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3869447

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3869447

Other Identifiers

ISSN

2164-7844,2164-7860

E-ISSN

2164-7860

DOI

10.1089/biores.2013.0040

How to access this item